Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prazosin for Post-Traumatic Headaches in Mild TBI
NCT02965027Phase 4Completed
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Start
- Nov 2016
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in post-traumatic headache (PTH) comparing Prazosin with Placebo (2 arms). Primary endpoint: Change From Baseline in Headache Frequency. Started Nov 2016; status: completed.
02
Drugs
prazosin
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT02965027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965027.